Global Melanoma Cancer Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 115 pages | ID: GFE52AB571EEN
GlobalInfoResearch

Abstracts

Melanoma Cancer is a skin cancer that develops due to expose of UV rays on the skin.

Scope of the Report:

Increasing incidence of melanoma across the globe and rising ozone layer depletion due to global warming are the major factors that are driving the market during the forecast period. Additionally, overexposure to radiation during certain treatments or exposure to chemicals during working, increasing awareness about cancer, and rising healthcare expenditure is also motivating the market.
The global Melanoma Cancer market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Melanoma Cancer.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Melanoma Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Melanoma Cancer market by product type and applications/end industries.

Market Segment by Companies, this report covers

• AB Sciences
• Incyte
• Merck
• Novartis
• Pierre Fabre
• Amgen
• AstraZeneca
• Bristol-Myers Squibb
• Daiichi Sankyo

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Non-invasive melanoma
• Invasive melanoma

Market Segment by Applications, can be divided into

• Hospitals
• Cancer Research Centers

Contents

1 MELANOMA CANCER MARKET OVERVIEW

1.1 Product Overview and Scope of Melanoma Cancer
1.2 Classification of Melanoma Cancer by Types
  1.2.1 Global Melanoma Cancer Revenue Comparison by Types (2017-2023)
  1.2.2 Global Melanoma Cancer Revenue Market Share by Types in 2017
  1.2.3 Non-invasive melanoma
  1.2.4 Invasive melanoma
1.3 Global Melanoma Cancer Market by Application
  1.3.1 Global Melanoma Cancer Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Cancer Research Centers
1.4 Global Melanoma Cancer Market by Regions
  1.4.1 Global Melanoma Cancer Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Melanoma Cancer Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Melanoma Cancer Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Melanoma Cancer Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Melanoma Cancer Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Melanoma Cancer Status and Prospect (2013-2023)
1.5 Global Market Size of Melanoma Cancer (2013-2023)

2 MANUFACTURERS PROFILES

2.1 AB Sciences
  2.1.1 Business Overview
  2.1.2 Melanoma Cancer Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 AB Sciences Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.2 Incyte
  2.2.1 Business Overview
  2.2.2 Melanoma Cancer Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Incyte Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
  2.3.1 Business Overview
  2.3.2 Melanoma Cancer Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Merck Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
  2.4.1 Business Overview
  2.4.2 Melanoma Cancer Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Novartis Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pierre Fabre
  2.5.1 Business Overview
  2.5.2 Melanoma Cancer Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Pierre Fabre Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.6 Amgen
  2.6.1 Business Overview
  2.6.2 Melanoma Cancer Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Amgen Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.7 AstraZeneca
  2.7.1 Business Overview
  2.7.2 Melanoma Cancer Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 AstraZeneca Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bristol-Myers Squibb
  2.8.1 Business Overview
  2.8.2 Melanoma Cancer Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Bristol-Myers Squibb Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.9 Daiichi Sankyo
  2.9.1 Business Overview
  2.9.2 Melanoma Cancer Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Daiichi Sankyo Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL MELANOMA CANCER MARKET COMPETITION, BY PLAYERS

3.1 Global Melanoma Cancer Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Melanoma Cancer Players Market Share
  3.2.2 Top 10 Melanoma Cancer Players Market Share
3.3 Market Competition Trend

4 GLOBAL MELANOMA CANCER MARKET SIZE BY REGIONS

4.1 Global Melanoma Cancer Revenue and Market Share by Regions
4.2 North America Melanoma Cancer Revenue and Growth Rate (2013-2018)
4.3 Europe Melanoma Cancer Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Melanoma Cancer Revenue and Growth Rate (2013-2018)
4.5 South America Melanoma Cancer Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Melanoma Cancer Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA MELANOMA CANCER REVENUE BY COUNTRIES

5.1 North America Melanoma Cancer Revenue by Countries (2013-2018)
5.2 USA Melanoma Cancer Revenue and Growth Rate (2013-2018)
5.3 Canada Melanoma Cancer Revenue and Growth Rate (2013-2018)
5.4 Mexico Melanoma Cancer Revenue and Growth Rate (2013-2018)

6 EUROPE MELANOMA CANCER REVENUE BY COUNTRIES

6.1 Europe Melanoma Cancer Revenue by Countries (2013-2018)
6.2 Germany Melanoma Cancer Revenue and Growth Rate (2013-2018)
6.3 UK Melanoma Cancer Revenue and Growth Rate (2013-2018)
6.4 France Melanoma Cancer Revenue and Growth Rate (2013-2018)
6.5 Russia Melanoma Cancer Revenue and Growth Rate (2013-2018)
6.6 Italy Melanoma Cancer Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC MELANOMA CANCER REVENUE BY COUNTRIES

7.1 Asia-Pacific Melanoma Cancer Revenue by Countries (2013-2018)
7.2 China Melanoma Cancer Revenue and Growth Rate (2013-2018)
7.3 Japan Melanoma Cancer Revenue and Growth Rate (2013-2018)
7.4 Korea Melanoma Cancer Revenue and Growth Rate (2013-2018)
7.5 India Melanoma Cancer Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Melanoma Cancer Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA MELANOMA CANCER REVENUE BY COUNTRIES

8.1 South America Melanoma Cancer Revenue by Countries (2013-2018)
8.2 Brazil Melanoma Cancer Revenue and Growth Rate (2013-2018)
8.3 Argentina Melanoma Cancer Revenue and Growth Rate (2013-2018)
8.4 Colombia Melanoma Cancer Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE MELANOMA CANCER BY COUNTRIES

9.1 Middle East and Africa Melanoma Cancer Revenue by Countries (2013-2018)
9.2 Saudi Arabia Melanoma Cancer Revenue and Growth Rate (2013-2018)
9.3 UAE Melanoma Cancer Revenue and Growth Rate (2013-2018)
9.4 Egypt Melanoma Cancer Revenue and Growth Rate (2013-2018)
9.5 Nigeria Melanoma Cancer Revenue and Growth Rate (2013-2018)
9.6 South Africa Melanoma Cancer Revenue and Growth Rate (2013-2018)

10 GLOBAL MELANOMA CANCER MARKET SEGMENT BY TYPE

10.1 Global Melanoma Cancer Revenue and Market Share by Type (2013-2018)
10.2 Global Melanoma Cancer Market Forecast by Type (2018-2023)
10.3 Non-invasive melanoma Revenue Growth Rate (2013-2023)
10.4 Invasive melanoma Revenue Growth Rate (2013-2023)

11 GLOBAL MELANOMA CANCER MARKET SEGMENT BY APPLICATION

11.1 Global Melanoma Cancer Revenue Market Share by Application (2013-2018)
11.2 Melanoma Cancer Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Cancer Research Centers Revenue Growth (2013-2018)

12 GLOBAL MELANOMA CANCER MARKET SIZE FORECAST (2018-2023)

12.1 Global Melanoma Cancer Market Size Forecast (2018-2023)
12.2 Global Melanoma Cancer Market Forecast by Regions (2018-2023)
12.3 North America Melanoma Cancer Revenue Market Forecast (2018-2023)
12.4 Europe Melanoma Cancer Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Melanoma Cancer Revenue Market Forecast (2018-2023)
12.6 South America Melanoma Cancer Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Melanoma Cancer Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Melanoma Cancer Picture
Table Product Specifications of Melanoma Cancer
Table Global Melanoma Cancer and Revenue (Million USD) Market Split by Product Type
Figure Global Melanoma Cancer Revenue Market Share by Types in 2017
Figure Non-invasive melanoma Picture
Figure Invasive melanoma Picture
Table Global Melanoma Cancer Revenue (Million USD) by Application (2013-2023)
Figure Melanoma Cancer Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Cancer Research Centers Picture
Table Global Market Melanoma Cancer Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Melanoma Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Melanoma Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Melanoma Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Melanoma Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Melanoma Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Melanoma Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Table AB Sciences Basic Information, Manufacturing Base and Competitors
Table AB Sciences Melanoma Cancer Type and Applications
Table AB Sciences Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Incyte Basic Information, Manufacturing Base and Competitors
Table Incyte Melanoma Cancer Type and Applications
Table Incyte Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Melanoma Cancer Type and Applications
Table Merck Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Melanoma Cancer Type and Applications
Table Novartis Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Pierre Fabre Basic Information, Manufacturing Base and Competitors
Table Pierre Fabre Melanoma Cancer Type and Applications
Table Pierre Fabre Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Melanoma Cancer Type and Applications
Table Amgen Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Melanoma Cancer Type and Applications
Table AstraZeneca Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Melanoma Cancer Type and Applications
Table Bristol-Myers Squibb Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Melanoma Cancer Type and Applications
Table Daiichi Sankyo Melanoma Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Global Melanoma Cancer Revenue (Million USD) by Players (2013-2018)
Table Global Melanoma Cancer Revenue Share by Players (2013-2018)
Figure Global Melanoma Cancer Revenue Share by Players in 2016
Figure Global Melanoma Cancer Revenue Share by Players in 2017
Figure Global Top 5 Players Melanoma Cancer Revenue Market Share in 2017
Figure Global Top 10 Players Melanoma Cancer Revenue Market Share in 2017
Figure Global Melanoma Cancer Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Melanoma Cancer Revenue (Million USD) by Regions (2013-2018)
Table Global Melanoma Cancer Revenue Market Share by Regions (2013-2018)
Figure Global Melanoma Cancer Revenue Market Share by Regions (2013-2018)
Figure Global Melanoma Cancer Revenue Market Share by Regions in 2017
Figure North America Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure Europe Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure South America Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Melanoma Cancer Revenue and Growth Rate (2013-2018)
Table North America Melanoma Cancer Revenue by Countries (2013-2018)
Table North America Melanoma Cancer Revenue Market Share by Countries (2013-2018)
Figure North America Melanoma Cancer Revenue Market Share by Countries (2013-2018)
Figure North America Melanoma Cancer Revenue Market Share by Countries in 2017
Figure USA Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure Canada Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure Mexico Melanoma Cancer Revenue and Growth Rate (2013-2018)
Table Europe Melanoma Cancer Revenue (Million USD) by Countries (2013-2018)
Figure Europe Melanoma Cancer Revenue Market Share by Countries (2013-2018)
Figure Europe Melanoma Cancer Revenue Market Share by Countries in 2017
Figure Germany Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure UK Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure France Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure Russia Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure Italy Melanoma Cancer Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Melanoma Cancer Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Melanoma Cancer Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Melanoma Cancer Revenue Market Share by Countries in 2017
Figure China Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure Japan Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure Korea Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure India Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Melanoma Cancer Revenue and Growth Rate (2013-2018)
Table South America Melanoma Cancer Revenue by Countries (2013-2018)
Table South America Melanoma Cancer Revenue Market Share by Countries (2013-2018)
Figure South America Melanoma Cancer Revenue Market Share by Countries (2013-2018)
Figure South America Melanoma Cancer Revenue Market Share by Countries in 2017
Figure Brazil Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure Argentina Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure Colombia Melanoma Cancer Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Melanoma Cancer Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Melanoma Cancer Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Melanoma Cancer Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Melanoma Cancer Revenue Market Share by Countries in 2017
Figure Saudi Arabia Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure UAE Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure Egypt Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure Nigeria Melanoma Cancer Revenue and Growth Rate (2013-2018)
Figure South Africa Melanoma Cancer Revenue and Growth Rate (2013-2018)
Table Global Melanoma Cancer Revenue (Million USD) by Type (2013-2018)
Table Global Melanoma Cancer Revenue Share by Type (2013-2018)
Figure Global Melanoma Cancer Revenue Share by Type (2013-2018)
Figure Global Melanoma Cancer Revenue Share by Type in 2017
Table Global Melanoma Cancer Revenue Forecast by Type (2018-2023)
Figure Global Melanoma Cancer Market Share Forecast by Type (2018-2023)
Figure Global Non-invasive melanoma Revenue Growth Rate (2013-2018)
Figure Global Invasive melanoma Revenue Growth Rate (2013-2018)
Table Global Melanoma Cancer Revenue by Application (2013-2018)
Table Global Melanoma Cancer Revenue Share by Application (2013-2018)
Figure Global Melanoma Cancer Revenue Share by Application (2013-2018)
Figure Global Melanoma Cancer Revenue Share by Application in 2017
Table Global Melanoma Cancer Revenue Forecast by Application (2018-2023)
Figure Global Melanoma Cancer Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Cancer Research Centers Revenue Growth Rate (2013-2018)
Figure Global Melanoma Cancer Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Melanoma Cancer Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Melanoma Cancer Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Melanoma Cancer Revenue Market Forecast (2018-2023)
Figure Europe Melanoma Cancer Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Melanoma Cancer Revenue Market Forecast (2018-2023)
Figure South America Melanoma Cancer Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Melanoma Cancer Revenue Market Forecast (2018-2023)